An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration
Nature Neuroscience2012Vol. 15(6), pp. 827–835
Citations Over TimeTop 1% of 2012 papers
Sabrina Lehmann, Christina Krüger, Boyoun Park, Katja Derkow, Karen Rosenberger, Jan Baumgart, Thorsten Trimbuch, Gina D. Eom, M. Hinz, David Kaul, Piet Habbel, Roland E. Kälin, Eleonora Franzoni, Agnieszka Rybak‐Wolf, Duong Thi Nguyen, Rüdiger W. Veh, Olaf Ninnemann, Oliver Peters, Robert Nitsch, Frank L. Heppner, Douglas T. Golenbock, Eckart Schott, Hidde L. Ploegh, F. Gregory Wulczyn, Seija Lehnardt
Related Papers
- → Systemic Cancer Therapy with a Small Molecule Agonist of Toll-like Receptor 7 Can Be Improved by Circumventing TLR Tolerance(2011)84 cited
- → Hepatitis C virus inhibits CD4 T cell function via binding to Toll-like receptor 7(2016)19 cited
- → 3-(5-Hydroxyphenyl)-5-Phenyl-2-Pyrazolines as Toll-Like Receptor 7 Agonists(2023)2 cited
- → Precise determination of toll-like receptor (TLR) 7 expression in multiple human tumor types(2014)
- Advance in toll-like receptor 7-mediated antiviral innate immune responses(2010)